Question 1

Has Danielle Armas received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $73,012,323 in general payments to Danielle Armas across 655 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Danielle Armas did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Danielle Armas come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Janssen Research & Development, LLC	243	$29,428,699
Vertex	6	$12,548,340
Regeneron	14	$7,242,116
Jazz Pharmaceuticals Inc.	20	$5,635,402
Travere Therapeutics, Inc.	39	$4,977,788
Amgen(2 entities)	23	$4,635,491
Xeris Pharmaceuticals, Inc.	21	$3,084,265
Indivior Inc.	17	$2,174,865
Modernatx, Inc.	89	$1,379,848
Novartis	3	$929,662
Takeda Pharmaceuticals U.S.A., Inc.	2	$523,459
Seqirus USA Inc	173	$404,890
AstraZeneca	1	$26,700
Orasure Technologies Inc.	2	$13,190
Merck	2	$7,609

Danielle Armas

Payments from drug & device makers

Who reported the general payments

How this compares

Other family medicine in Scottsdale